Other
Dec 2024The company said it planned to move to a Jiddu Beta prototype in early 2025, clinical trials in Q2 2025, and a full market launch in Q1 2026, indicating a stretched commercialization timeline.
SourceOne-hour antibiotic sensitivity testing
Company research
Public company, workplace, funding, and market signals
Overview
Astek Diagnostics is a Baltimore-area medical device / biotechnology startup developing the JIDDU platform, a benchtop diagnostic system for one-hour confirmation of urinary tract infections and antibiotic susceptibility testing, with planned expansion to CSF, wound effluent, and blood.
Primary product
JIDDU platform (benchtop analyzer for rapid UTI confirmation and antibiotic susceptibility testing)
Founded
2020
Headquarters
Baltimore, Maryland, United States
Team size
10-20 employees
Industry
Biotechnology Research
Sub-industry
Precision diagnostics / medical devices
Offices
Baltimore, Maryland, United States
Open Positions
0 jobs at Astek Diagnostics
No open positions
Check back later for new openings